Gaurav Gupta1, Preeti Sharma2, Pradeep Kumar3, Maliyannar Itagappa4. 1. Ph. D. Scholar, Department of Biochemistry, Santosh Medical College & Hospital (Santosh University) , Ghaziabad, India . 2. Assistant Professor, Department of Biochemistry, Santosh Medical College & Hospital (Santosh University) , Ghaziabad, India . 3. Professor, Department of Biochemistry, Santosh Medical College & Hospital (Santosh University) , Ghaziabad, India . 4. Professor and Head, Department of Biochemistry, Santosh Medical College & Hospital (Santosh University) , Ghaziabad, India .
Abstract
INTRODUCTION: Subclinical hypothyroidism shows the mimic reaction more like to frank hypothyroidism which creates the dilemma. Inflammatory markers can be helpful in assessment of adverse effects of subclinical hypothyroidism, are not very well studied in the past. So the aim of this study was to investigate the role of inflammatory markers in Subclinical hypothyroidism patients. MATERIALS AND METHODS: The study population consisted of 154 patients with recently diagnosed subclinical hypothyroidism and 100 healthy controls. TSH, FT4 & T3 were estimated by enzyme linked Immunosorbent assay (ELISA) for diagnosis of subclinical hypothyroidism. Total cholesterol, triglycerides, and HDL-C were estimated by spectrophotometric method. LDL - C was calculated by Friedewald formula. Inflammatory markers (ESR, C-reactive protein & Interleukin 6) were also estimated by enzyme linked Immunosorbent assay (ELISA). RESULTS: In this study the level of TSH Mean ± SD (11.12±4.17 vs 2.73±0.80) and T3 Mean ± SD (0.96±0.17 vs 1.08±0.26) were significantly higher (<0.001) in subclinical hypothyroidism. Serum concentration of FT4 was not significantly different between the groups. Total cholesterol, triglycerides, and LDL-C were significantly higher in patients group. While the level of HDL-C was significantly lower in SCH patients compared to euthyroid group. TSH level was positively correlated with inflammatory markers in subclinical hypothyroidism, which were significantly different in subclinical hypothyroidism. CONCLUSION: This study suggests that subclinical hypo-thyroidism patients have increased inflammatory markers along with dyslipidemia and due to that future risk of further development of cardiovascular disorder can occur. Level of inflammatory markers increases in patients as disease progress if left untreated.
INTRODUCTION:Subclinical hypothyroidism shows the mimic reaction more like to frank hypothyroidism which creates the dilemma. Inflammatory markers can be helpful in assessment of adverse effects of subclinical hypothyroidism, are not very well studied in the past. So the aim of this study was to investigate the role of inflammatory markers in Subclinical hypothyroidismpatients. MATERIALS AND METHODS: The study population consisted of 154 patients with recently diagnosed subclinical hypothyroidism and 100 healthy controls. TSH, FT4 & T3 were estimated by enzyme linked Immunosorbent assay (ELISA) for diagnosis of subclinical hypothyroidism. Total cholesterol, triglycerides, and HDL-C were estimated by spectrophotometric method. LDL - C was calculated by Friedewald formula. Inflammatory markers (ESR, C-reactive protein & Interleukin 6) were also estimated by enzyme linked Immunosorbent assay (ELISA). RESULTS: In this study the level of TSH Mean ± SD (11.12±4.17 vs 2.73±0.80) and T3 Mean ± SD (0.96±0.17 vs 1.08±0.26) were significantly higher (<0.001) in subclinical hypothyroidism. Serum concentration of FT4 was not significantly different between the groups. Total cholesterol, triglycerides, and LDL-C were significantly higher in patients group. While the level of HDL-C was significantly lower in SCH patients compared to euthyroid group. TSH level was positively correlated with inflammatory markers in subclinical hypothyroidism, which were significantly different in subclinical hypothyroidism. CONCLUSION: This study suggests that subclinical hypo-thyroidismpatients have increased inflammatory markers along with dyslipidemia and due to that future risk of further development of cardiovascular disorder can occur. Level of inflammatory markers increases in patients as disease progress if left untreated.
Authors: Young Joo Park; Eun Jung Lee; You Jin Lee; Sung Hee Choi; Joon Hyuk Park; Seok Bum Lee; Soo Lim; Won Woo Lee; Hak C Jang; Bo Youn Cho; Jong Inn Woo; Ki Woong Kim Journal: Arch Gerontol Geriatr Date: 2009-07-09 Impact factor: 3.250
Authors: Lauren E Johns; Kelly K Ferguson; Thomas F McElrath; Bhramar Mukherjee; Ellen W Seely; John D Meeker Journal: PLoS One Date: 2017-01-06 Impact factor: 3.240
Authors: Mahmoud A Allam; Youssef A Nassar; Hosameldeen S Shabana; Sadek Mostafa; Farag Khalil; Hendawy Zidan; Mohammed Abo-Ghebsha; Amir Abdelghaffar; Ahmed Essmat; Essam Elmahdi Journal: Int J Gen Med Date: 2021-11-06